Ignite Creation Date:
2024-05-06 @ 5:37 PM
Last Modification Date:
2024-10-26 @ 2:32 PM
Study NCT ID:
NCT05374369
Status:
COMPLETED
Last Update Posted:
2022-07-29
First Post:
2022-05-10
Brief Title:
Retrospective Analysis of Colorectal Cancer Screening Results
Sponsor:
Creative Biosciences Guangzhou Co Ltd
Organization:
Creative Biosciences Guangzhou Co Ltd
Study Overview
Official Title:
Retrospective Analysis of Colorectal Cancer Screening Results Among People Aged 40-74 in Shipai Town Dongguan City China
Status:
COMPLETED
Status Verified Date:
2022-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to retrospectively analyze colorectal cancer screening data of 40-74 year old population in Shipai Town Dongguan City
In this study the data of SDC2 Gene Methylation Test and Fecal Immunochemistry Test Q-FIT were screened from about 11000 subjects who participated in Colorectal Cancer Screening in Shipai Town Peoples Livelihood Project from May 2021 to May 2022 Data from 822 subjects with positive SDC2 Gene Methylation Test andor positive Fecal Immunochemistry Test Q-FIT results and with colonoscopy andor pathological results were selected for retrospective analysis
This retrospective study evaluated the screening performance of SDC2 Gene Methylation Test andor Fecal Immunochemistry Test Q-FIT for colorectal cancer using colonoscopy andor pathological results as the clinical standard method
In this study the data of SDC2 Gene Methylation Test and Fecal Immunochemistry Test Q-FIT were screened from about 11000 subjects who participated in Colorectal Cancer Screening in Shipai Town Peoples Livelihood Project from May 2021 to May 2022 Data from 822 subjects with positive SDC2 Gene Methylation Test andor positive Fecal Immunochemistry Test Q-FIT results and with colonoscopy andor pathological results were selected for retrospective analysis
This retrospective study evaluated the screening performance of SDC2 Gene Methylation Test andor Fecal Immunochemistry Test Q-FIT for colorectal cancer using colonoscopy andor pathological results as the clinical standard method
Detailed Description:
This study is a retrospective and observational study Subjects were not be given or offered any treatment during the study The investigator reviewed the patients medical history and examination report to determine eligibility based on inclusion and exclusion criteria
This study retrospectively analyse the basic information and the test results of SDC2 Gene Methylation Test and Fecal Immunochemistry Test Q-FIT of about 11000 subjects who participated in the Colorectal Cancer Screening in Shipai Town Peoples Livelihood Project from May 2021 to May 2022 A total of 822 subjects with positive SDC2 Gene Methylation Test results and or positive Fecal Immunochemistry Test Q-FIT results were screened out and their colonoscopy results were collected
822 subjects were classified according to colonoscopy andor pathological detection results and the screening performance of the SDC2 Gene Methylation Test and Fecal Immunochemistry Test Q-FIT for colorectal cancer was statistically analyzed
This study retrospectively analyse the basic information and the test results of SDC2 Gene Methylation Test and Fecal Immunochemistry Test Q-FIT of about 11000 subjects who participated in the Colorectal Cancer Screening in Shipai Town Peoples Livelihood Project from May 2021 to May 2022 A total of 822 subjects with positive SDC2 Gene Methylation Test results and or positive Fecal Immunochemistry Test Q-FIT results were screened out and their colonoscopy results were collected
822 subjects were classified according to colonoscopy andor pathological detection results and the screening performance of the SDC2 Gene Methylation Test and Fecal Immunochemistry Test Q-FIT for colorectal cancer was statistically analyzed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None